Protection of mouse islet isografts from nonspecific inflammatory damage by recipient treatment with nicotinamide and 15-deoxyspergualin
- 1 February 1996
- journal article
- Published by Elsevier in Cell Transplantation
- Vol. 5 (1) , 41-47
- https://doi.org/10.1016/0963-6897(95)02013-6
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Effect of 15-deoxyspergualin on immediate function and long-term survival of transplanted islets in murine recipients of a marginal islet massDiabetes, 1994
- Nicotinamide is a potent inducer of endocrine differentiation in cultured human fetal pancreatic cells.Journal of Clinical Investigation, 1993
- Cytotoxic action of IL‐1β against pancreatic islets is mediated via nitric oxide formation and is inhibited by NG‐monomethyl‐l‐arginineFEBS Letters, 1992
- Activated macrophages kill pancreatic syngeneic islet cells via arginine-dependent nitric oxide generationBiochemical and Biophysical Research Communications, 1991
- Hyperglycemia-induced B cell toxicity. The fate of pancreatic islets transplanted into diabetic mice is dependent on their genetic background.Journal of Clinical Investigation, 1990
- Differential roles of Mac-1+ cells, and CD4+ and CD8+ T lymphocytes in primary nonfunction and classic rejection of islet allografts.The Journal of Experimental Medicine, 1990
- PROLONGATION OF PANCREATIC ISLET XENOGRAFT SURVIVAL AND THYMUS ALTERATION BY 15-DEOXYSPERGUALINTransplantation, 1989
- Oxygen free-radical scavengers and immune destruction of murine islets in allograft rejection and multiple low-dose streptozocin-induced insulitisDiabetes, 1989
- Islet cytotoxicity of interleukin 1. Influence of culture conditions and islet donor characteristicsDiabetes, 1987
- Preventive and therapeutic effects of large-dose nicotinamide injections on diabetes associated with insulitis. An observation in nonobese diabetic (NOD) miceDiabetes, 1982